Sanofi (SNYNF)

Market Cap	120.50B
Revenue (ttm)	53.71B
Net Income (ttm)	10.72B
Shares Out	n/a
EPS (ttm)	8.65
PE Ratio	11.24
Forward PE	10.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111
Average Volume	15,885
Open	96.64
Previous Close	102.00
Day's Range	96.64 - 96.64
52-Week Range	90.05 - 122.03
Beta	0.44
RSI	50.41
Earnings Date	Oct 24, 2025

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR